The world of skin care is littered with products that contain skin-whitening ingredients and they’re often advertised as helping improve skin tone and reducing wrinkles.
But some skin-care experts say they’re actually creating a problem.
The U.S. Food and Drug Administration recently voted to ban the sale of epsilon products after the chemical company failed to report serious adverse events linked to the ingredients.
That was a blow to epsilons manufacturer, DuPont, which owns the epsilonic acid, which is used in products from Face Shop to Dove to Norelco.
In a statement, DuQuoin said it was disappointed that the FDA has “unilaterally removed the episodic acid safety certificate from its episoderm formulation product list” and the company “has asked the FDA to re-examine its safety and efficacy data” in light of the vote.
Epsilons safety certificates are used to show a product’s safety before it is approved for sale.
They are an important way for companies to verify whether the products are safe to use and are effective.
But DuQuinn said it is unclear how the FDA voted on the safety certificates.
In addition to the epimedium-10 safety certificate, the company also submitted a safety certificate to the U.K.’s Health and Safety Executive for “in-line epiming,” which means the product does not require skin contact.
It also submitted one for the epiduo-hydroxy acids, a product used in many epimeds.
DuQuoin also submitted safety certificates to the European Food Safety Authority and the World Health Organization.
Duquoin said the safety certificate for the “inline epi” was submitted in August.
The company’s epimedes were not approved for use until December and were sold at Wal-Mart and other retailers in the U, UK and France until February.
DuQuin said it plans to withdraw the epi-pump products from the U., UK and French markets after the FDA ruling, which DuQuino called a “political decision.”
The company plans to stop selling the epitapes at all retailers in France and the U until the FDA issues a revised certificate, which it said will be released soon.